CXCR4 and ischemia: For instance, intravenous injection of EVs from cardiac progenitor stem cells overexpressing the C-X-C chemokine receptor type 4 (CXCR4) improved cardiac function in a rat model of ischemia/reperfusion injury when compared with control EVs without CXCR4 overexpression [120].